Okla. Stat. tit. 63, § 63-2-803

This is the official text of Okla. Stat. tit. 63, § 63-2-803, part of Oklahoma’s Stat. tit. 63, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 63,." Browse the sections below, each linked to its official government source.

Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.

Approved cannabidiol for use in clinical trials

Official statutory text

A. Clinical trials conducted pursuant to a statewide

investigational new drug application established pursuant to the

provisions of this act shall only utilize cannabidiol which is:

1. From an approved source; and

2. Approved by the United States Food and Drug Administration

to be used for treatment of a condition specified in an

investigational new drug application.

B. The principal investigator and any subinvestigator may

receive cannabidiol directly from an approved source or authorized

distributor for an approved source for use in the clinical trials.

Status: in_force · Read it on the official government site

Need a lawyer in Oklahoma?

Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the Open US Law dataset (Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine (Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.